Global Avascular Necrosis Market
Pharmaceuticals

Global Avascular Necrosis Market Forecast 2026–2035 with Growth Opportunities

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

What Is The Expected Market Size Of The Avascular Necrosis Market From 2026 To 2030?

The avascular necrosis market has shown robust expansion in recent years. It is anticipated to increase from $0.89 billion in 2025 to $0.97 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 9.5%. The expansion observed in the past can be linked to factors like trauma-related bone injuries, excessive steroid consumption, alcohol intake, late diagnoses, and the rise in orthopedic procedures.

The avascular necrosis market is projected to experience robust expansion over the coming years. Its valuation is anticipated to reach $1.38 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 9.2%. This projected growth is primarily driven by factors such as the increasing adoption of advanced imaging techniques, ongoing research in regenerative medicine, a growing aging population, the rising prevalence of sports injuries, and continuous innovation in orthopedics. Key trends expected during this period encompass the escalating utilization of early diagnostic imaging, a wider embrace of joint-preserving therapeutic approaches, an increase in minimally invasive surgical interventions, the broadening of physical rehabilitation initiatives, and a stronger emphasis on intervening in the early stages of the disease.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=24476&type=smp

What Major Drivers Are Influencing Demand In The Avascular Necrosis Market?

The avascular necrosis market is anticipated to expand due to the increasing volume of knee and hip replacement procedures. These surgical interventions involve replacing compromised joints to alleviate pain, particularly in advanced instances of avascular necrosis. The rise in these surgeries stems from the widespread increase in osteoarthritis, a condition causing intense joint pain and mobility challenges, frequently necessitating surgery for relief and better quality of life. Avascular necrosis itself is a major factor driving the demand for knee and hip replacements, as it leads to bone tissue death from insufficient blood supply, resulting in joint breakdown and collapse. For example, data from November 2024, reported by the American Joint Replacement Registry (AJRR) – a US-based registry managed by the American Academy of Orthopaedic Surgeons – indicated that hip and knee arthroplasty procedures recorded in 2023 exceeded 4 million, representing an 18% rise from 2022. Consequently, the increasing frequency of knee replacements and hip surgeries is fueling the expansion of the avascular necrosis market.

Which Segments Are Included In The Analysis Of The Avascular Necrosis Market?

The avascular necrosis market covered in this report is segmented –

1) By Type: Trauma Related Avascular Necrosis, Non-Trauma Related Avascular Necrosis

2) By Diagnosis: Imaging, Biopsy, Computed Tomography Scan, Positron Emission Tomography, X-Ray

3) By Treatment Type: Medications, Surgery, Physical Therapy, Lifestyle Changes, Bone Grafting

4) By End-User: Hospitals, Specialty Clinics, Rehabilitation Centers, Ambulatory Surgical Centers, Home Care Settings

Subsegments:

1) By Trauma-Related Avascular Necrosis: Fracture-Induced Avascular Necrosis, Dislocation-Induced Avascular Necrosis, Post-Surgical Avascular Necrosis, Crush Injury-Related Avascular Necrosis, Sports Injury-Associated Avascular Necrosis

2) By Non-Trauma Related Avascular Necrosis: Steroid-Induced Avascular Necrosis, Alcohol-Induced Avascular Necrosis, Sickle Cell Disease-Associated Avascular Necrosis, Lupus-Related Avascular Necrosis, Radiation Therapy-Induced Avascular Necrosis, Idiopathic Avascular Necrosis

Which Key Industry Participants Are Active In The Avascular Necrosis Market?

Major companies operating in the avascular necrosis market are Stryker Corporation, Massachusetts General Hospital, Zimmer Biomet Holdings Inc., Smith & Nephew plc, Stanford Health Care, Apollo Hospitals Enterprise Limited, Singapore General Hospital Pte Ltd., Fortis Healthcare Limited, Narayana Hrudayalaya Limited, Bumrungrad International Hospital Co. Ltd., Aster DM Healthcare Limited, Mount Elizabeth Hospital Pte Ltd., Gleneagles Hospital Pte Ltd., Shalby Limited, Texas Orthopedic Hospital LLC, Regrow Biosciences Pvt. Ltd., Maxcure Hospitals Limited, Medicover Hospitals Private Limited, Mesoblast Limited, Athersys Inc.

Read the full avascular necrosis market report here:

https://www.thebusinessresearchcompany.com/report/avascular-necrosis-global-market-report

Which Region Shows The Strongest Potential For Future Growth In The Avascular Necrosis Market?

North America was the largest region in the avascular necrosis market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the avascular necrosis market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Avascular Necrosis Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=24476&type=smp

Browse Through More Reports Similar to the Global Avascular Necrosis Market 2026, By The Business Research Company

Peripheral Artery Disease Market Report 2026

https://www.thebusinessresearchcompany.com/report/peripheral-artery-disease-global-market-report

Peripheral Arterial Disease Market Report 2026

https://www.thebusinessresearchcompany.com/report/peripheral-arterial-disease-global-market-report

Rare Inflammatory Disease Treatment Market Report 2026

https://www.thebusinessresearchcompany.com/report/rare-inflammatory-disease-treatment-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model